This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
There were 125 drug shortages by the end of 2023.
As demand for semaglutide injections outstrips supply, unapproved formulations flood the market, raising safety concerns over substitute ingredients.
Health care providers and patients struggle to find critical medications as U.S. officials grapple with solutions.
The number of drug shortages being reported to the government’s mandatory reporting website “has increased dramatically in the last few weeks.”
